BELLUS Health reports results for fourth quarter and year ended December 31, 2009   >>

Roberto Bellini appointed President and CEO of BELLUS Health - Francesco Bellini to remain as Chairman of the Board; Charles Cavell appointed Deputy Chairman of the Board   >>

BELLUS Health reports results for third quarter of fiscal 2009   >>

shareprice.gif

BELLUS Health is a global health company focused on the development and commercialization of products to provide innovative health solutions to address critical unmet needs.

Nutraceuticals

OVOS Natural Health Inc., a wholly owned subsidiary of BELLUS Health Inc., has launched VIVIMIND™ (homotaurine), a patented, science-based natural health product shown to protect memory function.

In January 2010, the National Association of Pharmacy Regulatory Authorities (NAPRA) issued a directive to provincial pharmacists associations requesting that pharmacists not sell natural health products that have not been issued a Natural Health Product Number (NPN) by Health Canada.  The Company has taken a decision to temporarily cease its sales and marketing activities for VIVIMINDTM until a NPN number has been received for the product, expected in the middle of 2010.  The Company plans on re-launching the product in Canada at that time.  In the meantime, the product will still be available via the Internet.

Pharmaceuticals

BELLUS Health is advancing innovative programs based on the Company’s research and development of investigational product candidates to treat serious unmet medical needs.

>Presentation

Rodman & Renshaw 11th Annual Healthcare Conference

Dr. Francesco Bellini, Chairman, President & CEO

September 11, 2009

Presentation